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Introduction and Objective
Carcinoid Heart Disease (CaHD) develops from vasoactive substances 
released by neuroendocrine tumors which can cause significant 
patient morbidity and mortality without surgical intervention. There 
are currently very few studies on the condition as the rarity of the 
condition has not allowed for any high-quality trials.
Introduction and Objective
We performed a systematic review and meta-analysis to elucidate 
granular perioperative details and long-term outcomes in these 
patients. This will allow for better understanding of the condition 
and provide guidance to clinicians when managing this rare disease.
Research Question & Hypothesis
Purpose: To investigate the safety and efficacy of valve 
replacement in patients with carcinoid heart disease
Question: Can valve replacement in patients with a 
neuroendocrine tumor (NE) and carcinoid heart disease (CaHD) be 
done safely and with acceptable long term outcomes? What are 
the peri-operative characteristics?
Hypothesis: Valve replacement in patients with an NE and CaHD 
can be done safely with acceptable outcomes. Valve replacement 
will mostly involve the tricuspid valve.
Approach and Results
• Study design: Meta-Analysis
• Population: CaHD patients that receive 
Valvular surgery
• Intervention/Comparator: Not applicable
• Outcome: Survival, Relief of CaHD Symptoms
• Data source and collection: Systematic Search
• Rationale: Meta-analysis was performed in 
order to aggregate the small number of studies 
in the literature to evaluate a rare condition 
with a large sample size
Electronic search of Ovid, Scopus, Cumulative Index of 
Nursing and Allied Health Literature, and Cochrane 
Controlled Trials Register was performed to examine 
studies discussing surgical treatment of carcinoid 
disease. Nine articles comprising 416 patients were 






























240 188 122 103 79 65 53 48 41 Connolly et. al
32 29 7 6 5 4 3 3 Edwards et. al
19 16 10 8 7 6 6 6 Mokhles et. al
12 6 2 2 Komoda et. al






Analysis was performed using R software and included KM curve 
analysis along with other standard statistical analysis
Findings:
Conclusions
• Right heart failure was present preoperatively in 48% of patients
• Moderate to severe regurgitation was present in 97% of tricuspid and 
72% of pulmonary valves
• Thirty-day mortality was 9% and median survival was 3 years
• Valve replacement in patients with a NET and CaHD be done safely 
with acceptable outcomes. Valve replacement mostly involved 
Pulmonary Valve Replacement in addition to Tricuspid Valve 
Replacement  
• Mortality remains high, particularly at 5 and 10 years, primarily from 
progression of the primary disease
• Surgery was often delayed until NYHA III or IV Heart Failure and there 
is no consensus on how to monitor these patients, we suggest early 
referral to cardiology for close monitoring and early intervention
Future Directions
• Future studies should investigate cardiac monitoring protocols for 
patients with Carcinoid Syndrome and the effects of operative timing 
on survival
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